Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |